Sansure Biotech Inc. products

One Robot Doing Two Robots’ Job: 48 samples throughput≤100 min. (one-tube fast release technology 96 samples at less than 40 min.), minimum 3 batches (48 samples/batch x3) per day per unit, save lab space, high cost-effectiveness.

This diagnostic kit is an in vitro nucleic acid amplification test for the detection of low-risk papillomavirus (HPV)(type 6/11) DNA in reproductive tract secretions. It is intended for use as an aid in diagnosing an HPV (type 6/11) infection and patients with clinically suspected genital warts.

This High-risk HPV DNA (Genotype) Diagnostic Kit (PCR-Fluorescence Probing) is an in vitro nucleic acid amplification test for the detection of high-risk HPV (type 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68) present in exfoliated cells from females’ cervix. The test results can be used for identification of HPV genotypes.

15 High-risk HPV DNA Diagnostic Kit (PCR-Fluorescence Probing) is an in vitro nucleic acid amplification test for the detection of high-risk HPV (type 16, 18, 31, 33,35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68) present in exfoliated cells from females’ cervix. The test results can be used as an aid in the diagnosis of a high-risk HPV infection.

COVID-19 is an infectious disease caused by a newly discovered coronavirus named SARS-CoV2. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Elder people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. Sansure COVID-19 diagnostic solutions are used to directly detect  the presence of viral RNA, which will be detectable in patients before antibodies form or symptoms of the disease are present, which means the test results can tell whether or not that someone gets virus very early on in their illness.